SPDR® S&P Biotech ETF (XBI)

90.11
BATS BZX Real-Time Price
As of 11:18am ET
 -1.42 / -1.55%
Today’s Change
72.97
Today|||52-Week Range
98.79
-5.26%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Biotech ETF.

Performance

1 month+0.39% 3 years+10.79%
3 months-0.67% 5 years+5.07%
1 year+1.67% Since inception+13.27%
Data through 02/26/2020

Quote Details

Previous close$91.53
Open day’s range87.84 – 90.35
Net asset value (NAV)91.09 (02/25/2020)
Daily volume4,140,564
Average volume (3 months)4,755,390
Data as of 11:18am ET, 02/27/2020

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+5.07%+8.75%
Expense Gross exp ratio0.35%1.26%
Risk 5 year sharpe ratio0.320.45
Net assets$3.9B$3.2B
Average market cap$4.0B$41.2B
Average P/E--26.7
Dividend / Share--0.31%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
UTHR United Therapeutics Corp2.02%
NVTA Invitae Corp2.01%
EXAS Exact Sciences Corp1.99%
BMRN Biomarin Pharmaceutical Inc1.93%
VRTX Vertex Pharmaceuticals Inc1.92%
ALNY Alnylam Pharmaceuticals Inc1.81%
EXEL Exelixis Inc1.79%
GILD Gilead Sciences1.78%
SGEN Seattle Genetics Inc1.77%
IONS Ionis Pharmaceuticals Inc1.72%